Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
35,297
Total Claims
$1.9M
Drug Cost
914
Beneficiaries
$2,124
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-99%
Opioid rate vs peers
0.0% vs 2.6% avg
+99%
Cost per patient vs peers
$2,124 vs $1,068 avg
+82%
Brand preference vs peers
16.4% vs 9.0% avg
Brand vs Generic
Brand: 5,762 claims · $1.4M
Generic: 29,469 claims · $567K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,360 | $306K |
| Rivaroxaban | 377 | $82K |
| Linagliptin | 467 | $64K |
| Insulin Aspart | 245 | $64K |
| Dulaglutide | 67 | $53K |
| Pimavanserin Tartrate | 20 | $53K |
| Dapagliflozin Propanediol | 152 | $41K |
| Atorvastatin Calcium | 1,737 | $33K |
| Insulin Detemir | 153 | $31K |
| Sevelamer Carbonate | 76 | $30K |
| Dextromethorphan Hbr/Quinidine | 40 | $27K |
| Linaclotide | 43 | $24K |
| Fluticasone/Umeclidin/Vilanter | 41 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 118 | $22K |
| Sacubitril/Valsartan | 73 | $20K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
3.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data